ホーム>>Signaling Pathways>> Obesity, Appetite Control & Diabetes>> NAFLD & NASH>>GLP-2 (human) (trifluoroacetate salt)

GLP-2 (human) (trifluoroacetate salt) (Synonyms: Glucagon-like Peptide-2)

カタログ番号GC43764

グルカゴン様ペプチド2(GLP-2)は、栄養素の摂取に応答して小腸と大腸のL細胞でプログルカゴンを切断することによって形成される内因性ペプチドホルモンです。

Products are for research use only. Not for human use. We do not sell to patients.

GLP-2 (human) (trifluoroacetate salt) 化学構造

サイズ 価格 在庫数 個数
1mg
$478.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com


顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Glucagon-like peptide-2 (GLP-2) is an endogenous peptide hormone formed in L cells of the small and large intestine by cleavage of proglucagon in response to nutrient ingestion. In vivo, GLP-2 (43.75 μg twice a day) increases crypt cell proliferation, total weight of the small bowel, and mucosal thickness of the proximal and distal jejunum and ileum in mice. It increases jejunal mucosal surface area and reduces resection-induced decreases in SGLT-1 and GLUT-2 transporter abundance, as well as resection-induced increases in blood glucose levels and body fat loss, in a rat model of distal bowel resection. GLP-2 also increases intrahepatic lipid concentration, hepatic steatosis, and plasma concentrations of cholesterol and triglycerides in mice fed a high-fat diet but has no effect on mice fed a standard diet.

レビュー

Review for GLP-2 (human) (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for GLP-2 (human) (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.